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and subject to editorial review by 
the Department of Health Policy at 
Jefferson Medical College and Eli Lilly 
and Company.  It is supported through 
funding by Eli Lilly and Company.
The first 2 issues of Prescriptions for 
Excellence in Health Care addressed quality 
improvement in general terms (“Doing 
Things Right and Doing the Right Things 
– Quality and Safety in Health Care,” Fall 
2007) and from the hospital’s perspective 
(“Hospitals Take Ownership for Quality 
Improvement and Patient Safety,” 
Winter 2007). In this issue, we feature 
innovative strategies for improving quality 
of care in 4 different clinical settings.    
Pay for performance (P4P) continues 
to have both advocates and detractors. 
Although the Centers for Medicare and 
Medicaid Services  (CMS) and other 
organizations have promoted P4P as a 
tool for improving the quality of patient 
care, there remains little evidence to 
support its effectiveness at this juncture. 
The first article, “Effectiveness of Pay for 
Performance as a Quality Improvement 
Strategy,” chronicles a study comparing and 
contrasting the impact of P4P vs. public 
reporting vs. governance and oversight on 
specific measures of clinical quality in a large 
health care system – with surprising results.  
The second article, “Heart Failure 
Advocates Reduce Hospitalizations and 
Readmissions for Heart Failure,” describes 
an innovative strategy whereby non-
advanced practice nurses were trained 
and deployed at 6 different hospitals to 
promote guideline-based care.  The success 
of this program spurred the development 
of a National Heart Failure Training 
Program for heart failure advocates.     
An electronic health record was put to the 
test as a positive change agent in a study 
intervention targeting lipid management. 
“Lipid Management Study Shows 
Value of Electronic Health Records in 
Improving Quality of Care,” the third 
article, describes this randomized controlled 
study and discusses the outcomes.    
“Ambulatory Quality Measurement: 
The Jefferson University Physicians 
Experience,” the fourth article, details 
the development and implementation 
of a faculty-practice-wide ambulatory 
quality measurement initiative at our own 
institution.  After 2 years of activity, 14 
of the 16 Jefferson University Physicians 
( JUP) clinical departments had at least 1 
performance measurement initiative under 
way.  In addition, JUP became one of the 
first academic group practices to deploy an 
ambulatory patient safety assessment tool.  
Prescriptions for Excellence in Health 
Care is brought to Health Policy 
Newsletter readers by the Department 
of Health Policy in partnership with 
Eli Lilly and Company to provide 
essential information from the quality 
improvement and patient safety arenas. 
(continued on page 2)
Editorial
Quality Improvement 
Strategies: Frontline 
Experience 
By David B. Nash, MD, MBA
Editor-in-Chief
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Background
Catholic Healthcare Partners (CHP) 
is the largest health care provider in 
Ohio, with other hospitals located in 
Kentucky, Pennsylvania, and Tennessee. 
It is organized into 9 regional service 
areas in 5 states and includes 29 
hospitals.  When, in July 2003, Health 
and Human Services (HHS) Secretary 
Tommy G. Thompson announced a 
hospital-based pay-for-performance 
(P4P) demonstration project involving 
Premier, Inc., hospitals in CHP’s 
network had to decide whether or 
not to participate.  Because Premier, 
Inc. required that hospitals renew a 
subscription to a relatively expensive 
database tool as a condition for 
participation, cost was a limiting factor. 
Even if small-volume hospitals 
attained the highest performance 
ratings, they would not earn 
sufficient bonuses to offset the cost 
of the Premier database and the 
additional staff required to support 
data abstraction.   Ultimately, each 
of 4 regional health systems within 
the CHP network volunteered to 
have its largest volume facility join 
the project.  These systems believed 
that P4P was inevitable and saw 
the project as an opportunity to be 
better prepared for payment reform.  
CHP recognized the opportunity to 
study the impact of public reporting, 
P4P, and governance oversight on quality 
improvement in a multihospital system 
by comparing the P4P participants 
with a set of similar CHP hospitals that 
did not join the demonstration project.  
The study tested the question:  Did 
hospitals participating in the Center for 
Medicare and Medicaid Services’ (CMS) 
“Premier Hospital Quality Incentive 
Demonstration Project” have significantly 
different rates of improvement in the 
quality of care delivered compared 
to similar hospitals within the same 
system that did not participate in the 
voluntary demonstration project over 
the course of the 3-year project?
Study design
The study compared the impact of 1) 
the Premier Demonstration, 2) public 
reporting through the Hospital Quality 
Alliance (HQA), and 3) the evolving role 
of governance oversight, with particular 
attention to assessing the long-term 
impact of the Premier Demonstration 
project relative to internal and other 
external drivers of quality improvement.  
Effectiveness of Pay for Performance as a Quality 
Improvement Strategy
By Stephen R. Grossbart, PhD
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The final issue in this series of 
Prescriptions for Excellence in Health 
Care will be devoted to the role of 
health information technology and 
public reporting in improving quality 
and safety.  Finally, I am pleased 
to report that the response to this 
series has been very positive and that 
Lilly has agreed to partner with us 
on a second series of newsletters.  
As always, I am interested in your 
feedback and you can reach me by 
email at david.nash@jefferson.edu. 
David B. Nash, MD, MBA is the 
Dr. Raymond C. and Doris N. Grandon 
Professor of Health Policy and Chairman 
of the Department of Health Policy 
at Jefferson Medical College.
The Importance of HIT 
By Alex Azar
Health information technology 
(HIT) is generating a great 
deal of interest in the health 
care industry.  Theoretically, 
it gives us the ability to 
coordinate all existing medical 
knowledge about a patient 
and to incorporate new 
information on a real-time 
basis.  By amassing relevant 
data electronically from many 
different sources (eg, drug 
companies’ clinical trials, 
health insurers’ claims data, 
and physicians’ documentation 
of patients’ medical histories), 
HIT could allow us to 
know more about patients 
more quickly and in greater 
detail than ever before.   
As is often the case, theory 
is not easily translated into 
practice.  Individual providers 
have been slow to adopt new 
technology, and we have 
yet to develop the level of 
systems integration necessary 
for high-level information 
exchange.  In the next issue 
of Prescriptions for Excellence, 
this column and the feature 
articles will highlight HIT 
applications with a focus on 
positive solutions to benefit 
patients, physicians, and 
the industry as a whole.
Alex Azar is Senior Vice 
President for Corporate Affairs 
and Communications at 
Eli Lilly and Company
3Prescriptions for Excellence in Health Care
Within a single health care system, a 
test group of 4 acute care hospitals that 
participated in the demonstration project 
in federal fiscal years (FFY) 2004-2006 
was compared to a control group of 
5 hospitals that did not participate in 
the project.  The study limited analysis 
to 3 clinical areas that are included in 
the Premier Demonstration: 1) acute 
myocardial infarction (AMI), 2) heart 
failure (HF), and 3) pneumonia (PN).   
Performance was compared to a baseline 
year (2003) for both participating and 
nonparticipating hospitals to determine 
if the rate of improvement differed 
between the 2 cohorts of hospitals 
over the following 3 years based on a 
composite opportunity quality score.  
Study results
The 4 hospitals participating in the P4P 
demonstration project had significantly 
higher composite quality scores in each 
of the 3 clinical areas studied in Year 1 of 
the demonstration; however, by Year 3, 
the added pressure for public reporting 
of performance coupled with corporate 
goals requiring all hospitals in the 
system to be accountable at leadership 
and governance levels, eliminated 
the significant differences that once 
separated the 2 cohorts (Figure 1).  
Baseline
In the baseline year (2003), the 2 
cohorts had similar rates of overall 
performance, with participating 
hospitals starting at 80% and 
nonparticipating hospitals at 79%.  
Year 1
In 2004, participant hospitals improved 
their performance in HF and increased 
their overall composite quality scores to 
90% (vs. 86% for nonparticipants).  The 
Year 1 rate of increase for participants 
(9.8%) was significantly better than the 
nonparticipant rate (6.7%) (p= <.001). 
This difference was attributed primarily 
to HF care, where improvement from 
baseline to Year 1 for participating 
hospitals was 19% vs. 11% for 
nonparticipating hospitals (p= <.001).    
Year 2
In 2005, CHP expanded its internal 
accountability for quality performance at 
all hospitals in the system by including all 
measures in the Premier demonstration 
for AMI, HF, and PN with the goal of 
achieving a top quartile ranking in the 
3rd quarter.  Composite scores achieved 
by the 4 participating hospitals and the 
nonparticipating hospital group were 92% 
and 90% respectively.  The demonstration 
project hospitals had only a 2.6% 
increase in performance, significantly 
lower than the nonparticipant group, 
which improved by 4.4% (p= <.001).  
Year 3
By year 3, the difference in performance 
between the 2 cohorts had narrowed 
and the pace of improvement was 
virtually identical.  This was fueled 
in part by the increased internal 
accountability (ie, expansion of CHP 
performance measurements) and higher 
levels of expected performance.
Participants in the project achieved an 
overall composite quality score of 95% 
(2.7% improvement over Year 2) and 
nonparticipants improved their composite 
score by 3.5% to 94% (p= .015). 
Over the course of 3 years, performance 
of the 2 groups of hospitals converged.  
Participants in the demonstration 
project improved their overall composite 
quality score by 15.1% compared to 
14.6% for nonparticipants (p= .543) 
over the 3-year period (Figure 2).
Conclusion
Although the P4P demonstration clearly 
accelerated performance by participant 
hospitals in the first year of the project, 
performance by nonparticipants 
exceeded the performance of participants 
in years 2 and 3.  Both cohorts of 
hospitals performed at identical levels 
by 2006.  While nonparticipants had 
greater opportunity for improvement, the 
significant drivers of public reporting and 
internal focus on quality improvement 
(continued on page 4)
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HQA, Hospital Quality Alliance; AMI, Acute Myocardial Infarction; HF, Heart Failure; PN, Pneumonia
HQID, Hospital Quality Improvement Demonstration; SCIP, Surgical Care Improvement Project
Figure 1. Overall Composite Quality Score for HQA Measures for AMI, HF, and PN,
Catholic Healthcare Partners: CMS/Premier HQID Participants vs. Non-Participants
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(ie, tying senior executive accountability 
to performance on quality indicators 
and board oversight of corporate quality 
objectives and goals) created a strong 
environment for improvement.
Stephen R. Grossbart, PhD is Vice President 
for Quality Management at Catholic 
Healthcare Partners.  He can be reached at: 
srgrossbart@health-partners.org 
Additional Reading:
1. Grossbart SR. What’s the return? Assessing the effect  
 of “pay for performance” initiatives on the quality of  
 care delivery.  Medical Care Research and Review. 2006;  
 63(1 suppl):29S-48S.
Heart Failure Advocates Reduce Hospitalizations and Readmissions for Heart Failure
By Donald E. Casey, Jr, MD, MPH, MBA, FACP
Randomized clinical trials 
and observational studies have 
demonstrated the positive effects 
of multidisciplinary teams on heart 
failure (HF) readmissions. Many 
believe that such teams require the 
presence of an advanced practice 
nurse specializing in HF.  Catholic 
Healthcare Partners (CHP) 
demonstrated that the deployment 
of Heart Failure Advocates (HFA), 
non-advanced practice nurses 
specially trained to promote 
guideline-based care, can result in 
significant reductions in both HF 
hospitalizations and associated costs.
HFA Initiative
In 2004, an initial cohort of 6 HFAs 
were recruited, trained, and deployed 
in 6 different CHP hospitals in 
different geographic locations.  The 
training was based extensively upon 
current clinical practice guidelines 
for HF published by the American 
Heart Association (AHA) and the 
Heart Failure Society of America.  
Elements of the HFA training included: 
1.  Evidence-based approaches to 
medication adherence and 
management, especially for 
angiotensin-converting enzyme 
(ACE) inhibitors /angiotensin receptor 
blockers (ARB) and beta-blockers
2.  Development of new and extensive 
patient-centered care coordination 
skills not currently part of traditional 
hospital case management, with 
special emphasis on post-discharge 
telephonic follow-up, communication 
with physicians responsible for 
subsequent outpatient care post 
hospitalization, and doing “whatever 
it takes” to improve patients’ quality 
of life through self-management
3.  Special organizational skills, 
such as leadership, influence, clinical 
and administrative credibility 
(especially with physicians and 
hospital CEOs), creative problem 
solving, and conflict resolution. 
Results and discussion
Initial analysis showed that the “sickest” 
patients admitted with DRG (diagnosis-
related group) 127 and enrolled under 
the care of the HFAs experienced 
fewer readmissions and longer intervals 
between admissions than HF patients 
who received the usual care.  
Further analysis revealed that patients 
under the care of HFAs experienced a 
66% reduction in hospitalizations with 
a 41% reduction in all-cause 30-day 
readmissions when compared with 
other HF patients who were not cared 
for by HFAs.  On a quarterly basis, the 
30-day all-cause readmission rate for HF 
patients cared for by HFAs consistently 
ranged between 1% and 10%, compared 
to national readmission rates of 20%.    
Enrollment of HF patients in the 
HFA program had a strong effect on 
readmissions.  Days elapsed without 
readmissions doubled in the post-
enrollment period (469 days) compared 
with the pre-enrollment period (211 
HQA, Hospital Quality Alliance; AMI, acute myocardial infarction; HF, heart failure; PN, pneumonia; HQID, 
Hospital Quality Incentive Demonstration
Figure 2. Overall Composite Quality Score for HQA Measures for AMI, HF, and PN, 
Catholic Healthcare Partners: CMS/Premier HQID Participants vs. Non-Participants
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days).  The HFA patients experienced 
fewer admissions and longer periods 
of time without readmissions.  This 
translates into improved health status 
and lower costs.  See Table 1 and 
Figure 1 for more analysis of results.
  
Because of the remarkable success of 
this intervention, CHP partnered with 
the National Heart Failure Training 
(NHeFT) Program to develop a 
nationally available program for training 
nurses to become HFAs.  Specially 
trained nurses without advanced practice 
degrees can have a significant impact on 
avoiding hospitalizations for patients with 
HF.  Although this training program 
is in the early stage of implementation, 
hospitals interested in developing a HFA 
program are strongly encouraged to 
participate in the NHeFT Program.   
Lessons learned
1. Many nonacademic health 
systems do not have direct 
access to nationally recognized 
clinical expertise for HF.  
Such access can make a 
huge difference in quality 
improvement efforts.
2. Appropriate organizational 
goals and incentives based 
upon standardized quality 
measurements (ie, American 
College of Cardiology [ACC]/
AHA) are powerful motivators 
for promoting and improving 
quality.  Standardized 
“tools” are less important. 
3. Making the transition from 
focusing on acute hospital 
management to reducing hospital 
readmissions for HF is difficult and 
currently not profitable for most 
hospital systems; currently hospitals 
must focus more on chronic care.
4. Significant expertise in 
evidence-based HF care can 
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Table 1. Analysis of 30- and 60-day Readmissions for Heart Failure Patients:
Comparisons between Heart Failure Advocates and Usual Care
Figure 1:  Kaplan Meier Curves for 30-day Readmissions for Patients with Heart Failure: 
Comparisons between Heart Failure Advocates and Usual Care
All Cause Readmission %
Difference
Heart Failure Readmission %
DifferenceAdvocate Control Advocate Control
30-day readmissions per patient 0.16 0.19 15.79% 0.03 0.05 40.00%
Patients with at least one 30-Day Readmission 13.83% 14.66% 5.66% 3.22% 4.75% 32.21%
60-day readmissions per patient 0.29 0.33 12.12% 0.08 0.08 0.00
Patients with at least one 60-Day Readmission 22.19% 23.32% 4.85% 7.40% 7.68% 3.65%
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Lipid Management Study Shows Value of Electronic 
Health Records in Improving Quality of Care
By James Gill, MD, MPH
be provided by well-trained 
HFAs without advanced 
practice nursing training to 
improve quality of care and 
prevent readmissions for 
patients with chronic HF.   
Donald E. Casey, Jr, MD, MPH, MBA, 
FACP is Vice President for Quality and Chief 
Medical Officer of Atlantic Health, Morristown, 
NJ.  He is the former Chief Medical Officer for 
Catholic Healthcare Partners.  Dr. Casey can 
be reached at: don.casey@atlantichealth.org. 
Despite evidence that controlling 
cardiovascular risk factors reduces 
cardiovascular disease morbidity 
and mortality in persons with and 
without coronary heart disease, 
research has shown that physicians in 
clinical practice often do not follow 
national guideline recommendations 
for the detection and treatment of 
hyperlipidemia.1-3 In addition to 
promoting better organization of 
patient data such as medications and 
test results, studies have concluded that 
computerized systems, including the 
electronic health record (EHR), can 
aid in improving the quality of care by:
•	 Providing automated reminders 
 of needed tests.4 
•	 Highlighting detection/treatment  
 guidelines during office visits.5
Although several studies showed 
improvement in lipid testing when 
EHR aids were used, few examined 
the impact of the EHR on lipid 
control (ie, test outcomes).  
Study design
To better determine the benefits of 
EHRs in lipid management, researchers 
(continued on page 6)
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conducted a randomized, controlled 
study to examine the impact of 
an EHR-based intervention for 
lipid management in a network 
of primary care practices.  The 
intervention integrated nationally 
recognized Adult Treatment Panel 
III (ATP-III) guidelines from the 
National Cholesterol Education 
Program (NCEP) at the point of 
care using the EHR.  The hypothesis 
was that patients of physicians at 
the intervention offices would be 
more likely to have up-to-date lipid 
testing, to be at their lipid goal, and 
to be on medications if not at goal 
than patients at nonintervention 
offices (control group).  
The study’s primary focus was to 
determine whether the intervention 
group showed greater improvement 
than the control group on 4 main 
outcome measures: (a) lipids at goal, (b) 
lipid testing completed, (c) appropriate 
use of lipid medications in high-
risk patients, and (d) lipid diagnoses 
recorded.  The study included 25 
primary care practices within the 
Medical Quality Improvement 
Consortium (MQIC), which uses 
the Centricity® outpatient EHR and 
regularly downloads de-identified 
clinical data into a secure central 
repository.  All active patients, 
ages 20 to 79, for each of the 105 
participating physicians were included 
and categorized as high, medium, 
or low risk based on modified ATP-
III criteria.  Overall, there were 
64,150 patients in this study with 
26,696 in the intervention group 
and 37,454 in the control group. 
Study intervention
An interactive, point-of-care EHR 
disease management tool was integrated 
into the physician’s usual EHR encounter 
form in the following manner:
•	 The screening page appeared  
 during a patient visit if  
 lipid testing was overdue or  
 if lipid goals were not met.
•	 The assessment page highlighted  
 the patient’s lipid goal and  
 whether or not he/she met that  
 goal, using information from the  
 EHR.  The physician could modify 
 that information (and possibly  
 change the patient’s lipid goal)  
 and/or access more information  
 on the ATP-III criteria.
•	 The management page allowed  
 the physician to add or change  
 medications, order lab tests,  
 print patient education handouts,  
 and document counseling,  
 as well as directly access Web  
 sites for physician or patient  
 education about hyperlipidemia.  
 
The intervention employed other 
reporting tools to identify patients 
who were not seen in the office and 
who did not meet lipid management 
criteria.  These tools generated lists 
of patients who had not been recently 
tested for hyperlipidemia or were 
not at goal for lipid management, 
and provided personalized letters for 
physicians to send to these patients.  
Intervention offices were asked to run 
these reports once at the beginning of 
the study and again after 6 months. 
Outcome Variables
The 3 main outcome variables were:
•	 Proportion of patients tested  
 adequately for hyperlipidemia  
 (a full lipid panel within 1  
 year for persons at high risk, and  
 within 5 years for all others);
• Proportion of patients whose 
 most recent low-density  
 lipoprotein cholesterol (LDL-C)  
 was at goal (<100 for high risk, 
 <130 for moderate risk, and  
 <160 for low-risk patients);
• Proportion of high-risk patients  
 with an LDL-C >130 who were 
 prescribed lipid-lowering  
 medications.  Patients with no 
 LDL-C or whose LDL-C was 
 nonnumerical (eg, “unable to 
 calculate” or “normal”) were  
 excluded from the analyses of  
 lipids at goal and medication use.  
Results and Discussion
Results showed that the likelihood 
of achieving the desired outcomes 
increased significantly from baseline 
to end point for all groups, with few 
exceptions. However, the increases 
were generally modest; the largest 
increase (7%) was in the likelihood 
of high-risk persons being on lipid-
lowering medication if their lipids 
were not at goal.  Of interest, the 
increases were observed equally in 
the intervention and control groups. 
After controlling for differences in patient 
and physician characteristics between 
the 2 groups and for the “clustering” 
effect, the only outcome for which the 
intervention group showed a significant 
improvement was lipid testing for high-
risk patients.  These results are surprising 
given that EHR interventions have been 
shown to improve preventive care.  The 
researchers cited possible reasons for 
the marginal differences between the 
intervention and control groups 1 year 
after implementing the EHR-based 
disease management intervention:
•	 The Hawthorne effect (ie,  
 persons who know their behavior 
 is being observed may be more  
 likely to improve that behavior); 
•	 Potential for similar quality  
 improvement interventions  
 implemented within the control 
 group during the study period (eg, 
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 managed care disease management 
 initiatives); 
• High baseline parameters that left 
 little room for improvement (Note:  
 rates in this study were higher than  
 those found in previous studies); 
• Physicians, in general, approaching  
 lipid management more aggressively  
 than in previous study periods;
• Lack of office staff involvement in 
 the intervention.
Despite the relatively small increase 
in quality of care reflected in the 
study, most physicians surveyed said 
they found the intervention both 
helpful and useful in their practices.
Conclusion
Researchers concluded that, although 
EHRs are useful tools, they are not a 
panacea for improving quality without 
changing other components of usual 
office care.  They suggest that future 
studies may need to examine more 
comprehensive interventions that include 
office staff in a team approach to care. 
James Gill, MD, MPH is President of Delaware 
Valley Outcomes Research and Associate Professor 
in the Department of Family and Community 
Medicine at Jefferson Medical College.  He 
can be reached at gillj@devoresearch.com.
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Ambulatory Quality Measurement:
The Jefferson University Physicians Experience
By Neil I. Goldfarb
Historically, quality measurement and 
improvement in ambulatory care was 
undertaken at the health plan level.  
Thanks to the standardized Health 
Plan Employer Data and Information 
Set (HEDIS®) measurement set, 
emphasis is increasingly being placed 
on measuring quality at the level 
of the individual provider group or 
provider.   As measures are developed, 
pilot tested, and disseminated, they are 
fueling quality improvement and value-
based purchasing initiatives such as 
•	 public reporting of provider- 
 level quality data, 
•	 consumer incentives for choosing  
 higher quality providers, 
•	 selective contracting with  
 higher quality providers, and 
•	 pay-for-performance (P4P)  
 programs for ambulatory  
 care providers.  
Jefferson University Physicians ( JUP), 
the faculty practice plan of Thomas 
Jefferson University, consists of over 400 
physicians in primary care and specialty 
care practices.  As a large multispecialty 
academic group practice, JUP faces 
many challenges in ensuring that quality 
care is provided consistently across all 
practice sites and providers.  A survey 
conducted in 2003 found that JUP and 
most of its colleagues in the University 
HealthSystem Consortium were just 
beginning to recognize the need to 
address ambulatory care quality.1 
In 2004, JUP reconstituted its Clinical 
Care Subcommittee (CCS) as the main 
oversight body for ambulatory care quality 
measurement and improvement.  The CCS 
includes representation from all clinical 
departments.  JUP leadership agreed to 
fund a full-time quality review nurse and a 
half-time data analyst to support the CCS’ 
work.  Additional resources were provided 
in-kind from Jefferson Medical College’s 
Department of Health Policy, including the 
Department’s Chair, who agreed to Chair 
the CCS, and the Department’s Director of 
Research, who assumed the responsibility 
of JUP Director of Ambulatory Care 
Performance Improvement.
Initially, the CCS focused on supporting 
each of the 16 clinical departments 
in developing and implementing at 
least 1 outpatient quality measurement 
activity.  The CCS staff met with 
representatives of each department to 
discuss possible measures and provided 
information on existing specialty-relevant 
measures (eg, HEDIS or HEDIS-like 
measures), specialty society guideline and 
measurement development efforts, and the 
emerging measurement sets endorsed by 
the National Quality Forum and the AQA 
Alliance.  Where well-established measures 
did not exist or did not seem relevant to the 
practice, the practice representatives were 
asked to propose measures based on criteria 
of importance to the practice, feasibility of 
measurement, and the belief that a quality 
issue might exist in the area of study.  
Nearly all departments were highly 
receptive to this performance 
measurement initiative and, within 
the first 2 years of activity, 14 of 16 
departments had at least 1 initiative under 
way.  Examples of projects include:
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• Measuring blood pressure control  
 for patients with hypertension  
 in the Internal Medicine and  
 Family Medicine practices
• Using the SF-12 (www.iqola. 
 org/instruments.aspx) survey  
 tool to measure health-related  
 quality of life (outcomes) for  
 patients in the Rehabilitation  
 Medicine outpatient practice
•	 Reviewing records for patients who  
 were seen in the Emergency 
 Department (ED), returned to the ED  
 within 72 hours, and were admitted to 
 the hospital, in order to determine if a  
 quality-of-care problem occurred  
 during the initial visit
•	 Surveying patients who underwent 
 ambulatory surgery to identify  
 postoperative infection rates and 
 other complications
•	 Tracking follow-up on biopsies  
 and time to patient notification  
 in the Dermatology practice
One major initiative, designed by the 
Otolaryngology Department with 
support from the CCS staff, examined 
documentation of smoking history 
and smoking cessation counseling for 
patients with head and neck cancers.  
Several rounds of measurements and 
feedback to providers in this practice, 
including redesigned charting tools and 
patient education materials, resulted in a 
marked improvement in history taking, 
counseling, and referring patients who 
continued to smoke.  This project is being 
expanded into a major public health 
initiative spanning all departments.  
JUP is one of the first academic group 
practices in the nation to deploy the 
Physician Practice Patient Safety Assessment 
(PPPSA), an ambulatory patient safety 
assessment tool developed by the Medical 
Group Management Association, the 
Institute for Safe Medication Practices, and 
the Health Research & Educational Trust 
(www.physiciansafetytool.org). 
The tool is being completed by a 
multidisciplinary team within each 
practice site to identify potential areas 
for safety improvement in domains 
such as medication safety, patient 
handoffs and transitions, and practice 
management and culture.  In addition 
to helping departments identify areas for 
improvement, the responses will be used to 
compare JUP performance against national 
benchmarks, identify best practices across 
JUP departments, and identify areas for 
JUP-wide safety improvement initiatives.
National measurement, reporting, and 
P4P initiatives play an expanding role in 
shaping the JUP quality measurement 
and improvement agenda; eg, JUP is 
participating in the Physician Quality 
Reporting Initiative (PQRI) developed by 
the Centers for Medicare and Medicaid 
Services (CMS) (www.cms.hhs.gov/pqri/).  
Viewed as the precursor to a federal P4P 
program, PQRI is a pay-for-reporting 
program in which practices may earn 
bonus payments for reporting on quality 
of care using a set of CPT-II (Current 
Procedural Technology-II) codes.  In 
addition to familiarizing providers and 
practice administrators with a new lexicon 
and set of billing codes, implementation of 
PQRI has required the development of new 
billing forms to supplement existing ones.  
Further complicating matters, other payers, 
including the local Blue Cross Blue Shield 
plan, have developed their own P4P systems 
using a largely different set of measures.
An electronic medical record (EMR) 
system, to be implemented in 2008, should 
greatly facilitate the CCS team’s ability 
to measure practice- and provider-level 
performance efficiently, and to accurately 
report performance data to CMS and 
other payers.  The CCS team is working 
with the clinical departments and the 
EMR implementation team to ensure that 
record templates include essential fields for 
quality measurement (eg, date of patient 
notification of test results) and that these 
fields will be linked with appropriate alerts 
and flags (eg, reminders that patients have 
not been notified of test results).  Recent 
CCS meeting discussions have focused on 
how to use the EMR as a tool to promote 
quality and how to dispel commonly 
held beliefs that the EMR will solve all 
the practices’ quality and safety issues.
Summary
Performance measurement and 
improvement activities have advanced 
rapidly within the JUP academic group 
practice over the past 5 years.  The 
commitment of JUP leadership to 
quality improvement is evidenced by 
the continued dedication of financial 
resources to the staffing of the CCS’ 
activities (funding increased from 1.5 to 
2.0 FTE’s as of July 2007).  While many 
of JUP’s initial performance measurement 
activities were home grown, the agenda 
is shifting toward use of standardized 
tools and participation in local and 
national reporting and P4P programs.  
Implementation of an EMR will 
undoubtedly simplify some aspects of the 
measurement and reporting processes, but 
much work will be needed to determine 
how best to deploy this tool for true quality 
improvement.  Participation in the national 
University HealthSystem Consortium 
and partnering with other organizations 
at the local and national level are critical 
to continued learning and development 
and dissemination of best practices for 
ambulatory group practice improvement.
Neil I. Goldfarb, Vice Chair for Research 
in the Department of Health Policy at 
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Ambulatory Care Performance Improvement 
for Jefferson University Physicians. He can 
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